BioNTech SE
BNTX
$101.81
$3.053.09%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -171.78% | -117.67% | -112.20% | -98.16% | -90.07% |
| Total Depreciation and Amortization | 61.67% | 60.12% | 70.79% | 55.63% | 52.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.53% | 77.71% | 89.32% | 79.38% | -159.59% |
| Change in Net Operating Assets | -78.44% | -48.69% | -44.07% | 47.82% | 27.99% |
| Cash from Operations | -96.40% | -71.95% | -66.99% | -31.62% | -59.35% |
| Capital Expenditure | -14.56% | -2.83% | 9.40% | 16.44% | 21.08% |
| Sale of Property, Plant, and Equipment | -- | 166.68% | -64.55% | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.51% | -33.84% | -98.27% | -1,001.61% | -2,169.72% |
| Cash from Investing | 69.82% | -21.51% | -98.32% | -724.47% | -80,613.67% |
| Total Debt Issued | -- | -33.33% | -50.00% | -62.50% | -62.50% |
| Total Debt Repaid | -13.61% | -36.46% | -38.26% | 0.26% | 32.55% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 99.90% | 73.36% | 64.01% | 25.13% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 94.12% | 93.78% | 68.26% | 71.18% | 42.55% |
| Foreign Exchange rate Adjustments | 215.44% | -725.33% | -112.75% | 225.41% | -119.28% |
| Miscellaneous Cash Flow Adjustments | -98.06% | 38,089.00% | 29,675.30% | 21,142.98% | 34,826.99% |
| Net Change in Cash | 11.32% | -5,620.30% | -183.48% | -156.01% | -118.16% |